source
- What RevMed’s pancreatic cancer drug meant for one patientWhy did a presentation on Revolution Medicines' pancreatic cancer drug get a standing ovation? Why did biotech stocks perform so badly this week? Find out on "The Readout LOUD."STAT · 1mo ago↗ source
- STAT+: Otsuka kidney drug slowed loss of function, but less than expected, in late-stage trialOtsuka’s Voyxact slowed the loss of kidney function after one year in patients with a chronic autoimmune kidney disease, but the benefit was less than expected.STAT · 1mo ago↗ source
- Acting FDA chief isn't interested in permanent roleActing FDA Commissioner Kyle Diamantas isn't interested in keeping the job and the search for a permanent replacement is progressing, according to a source familiar with the process. An announcemen…